- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04708028
Animal Assisted Therapy in Dentistry (ATT)
Animal Assisted Therapy's Effects on Orthodontic Patients
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Laura A Jacox, DMD, PhD, MS
- Phone Number: 919-537-3424
- Email: ljacox@live.unc.edu
Study Contact Backup
- Name: S.T. Phillips, BSDH
- Phone Number: 9195373422
- Email: sherrill_phillips@unc.edu
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Recruiting
- General & Oral Health Center
-
Contact:
- S.T. Phillips
- Phone Number: 919-537-3422
- Email: sherrill_phillips@unc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
120 participants total (60 no therapy dog exposure, 60 with therapy do exposure) recruited from UNC Graduate Pediatric Dental Clinic
1 quadrant of restorative dental procedures requiring a handpiece (could include multiple fillings, sealants and/or stainless-steel crowns) and/or extraction(s) not requiring sedation (no pharmacological sedation) 7-17 years of age any gender or race/ethnicity moderate dental anxiety with a Frankl score of 2-3 No fear of dogs or dog allergies
Description
Inclusion Criteria: Subjects must meet all of the following inclusion criteria to be eligible for enrollment in the study:
- 7-17 years of age
- Patient undergoing 1 quadrant restorative dental procedure requiring a handpiece (e.g. multiple fillings, sealants and/or stainless-steel crowns) and/or extraction(s)
- History of moderate dental anxiety with a Frankl score of 2-3 based on Epic chart review
Exclusion Criteria Subjects presenting with any of the following will not be included in the study:
- Patients with developmental delay/special needs, Autism Spectrum Disorders (ASDs), craniofacial defects, chronic pain conditions, and/or dental syndromes
- No history of dental anxiety
- Moderate to severe allergy to dogs
- Previous traumatic experience with a dog and/or self-reported fear of dogs
- Patients who are not receiving dental care requiring a handpiece (for ex, prophylaxis only)
- Patients with severe, documented xerostomia
- Patients receiving sedation (pharmacological and conscious sedation) or general anesthesia
- Patients who will have physical restraints placed during the dental procedure
- Patient scheduled to have sedation or general anesthesia
- Severe acute or chronic medical or psychiatric condition(s) that would interfere with the interpretation of results, and in the judgement of the Investigator, would make the subject inappropriate for entry into the trial
- Patient with developmental/cognitive disability that cannot self-assent, comprehend and follow the requirements of the study based on research site personnel's assessment.
- Inability or unwillingness of individual and legal guardian/representative to give written informed assent (from child) and consent (from adult).
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
---|
Control
No exposure to the therapy dog.
|
Dog Therapy
Introduced to a therapy dog and allowed to pet the dog for up to 2 minutes (timed) prior to the dental procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Heart Rate during Dental Injection
Time Frame: During dental injection, approximately 1 minute.
|
Beats per minute during dental injection.
Heart rate measured using wrist-worn Shimmer.
|
During dental injection, approximately 1 minute.
|
Mean Heart Rate Post-Dental Procedure
Time Frame: After dental procedure, approximately 1-2 minutes.
|
Beats per minute after dental procedure.
Heart rate measured using wrist-worn Shimmer.
|
After dental procedure, approximately 1-2 minutes.
|
Salivary Cortisol during Dental Injection
Time Frame: During dental injection, approximately 1 minute.
|
To measure stress levels salivette swab will be placed in child's cheek to absorb saliva.
|
During dental injection, approximately 1 minute.
|
Salivary Cortisol Post-Dental Procedure
Time Frame: After dental procedure, approximately 1-2 minutes.
|
To measure stress levels salivette swab will be placed in child's cheek to absorb saliva.
|
After dental procedure, approximately 1-2 minutes.
|
Salivary Amylase during Dental Injection
Time Frame: During dental injection, approximately 1 minute.
|
To measure stress levels salivette swab will be placed in child's cheek to absorb saliva.
|
During dental injection, approximately 1 minute.
|
Salivary Amylase Post-Dental Procedure
Time Frame: After dental procedure, approximately 1-2 minutes.
|
To measure stress levels salivette swab will be placed in child's cheek to absorb saliva.
|
After dental procedure, approximately 1-2 minutes.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laura A Jacox, DMD, PhD, MS, University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 19-1911
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Dr. Nazanin AlaviActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States